Polypharmacy in the Hospitalized Older Adult: Considerations for Safe and Effective Treatment.
Autor: | DiConti-Gibbs A; Division of Geriatrics, Hospital, Palliative, and General Internal Medicine, Keck School of Medicine of USC, 2020 Zonal Ave, IRD 306, Los Angeles, CA 90033. Electronic address: Analiese.diconti-gibbs@med.usc.edu., Chen KY; Primary Care, Welbe Pacific/PACE, 50 Alessandro Place, A20, Pasadena, CA 91105, USA; LAC+USC/Keck School of Medicine Geriatric Fellowship, 2020 Zonal Ave, IRD 306, Los Angeles, CA, 90033., Coffey CE Jr; LAC+USC Medical Center, Suite C2K100, Room 115, 2051 Marengo Street, Los Angeles, CA 90033, USA; Keck School of Medicine of USC, 1975 Zonal Ave, Los Angeles, CA 90033. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinics in geriatric medicine [Clin Geriatr Med] 2022 Nov; Vol. 38 (4), pp. 667-684. |
DOI: | 10.1016/j.cger.2022.07.011 |
Abstrakt: | Care for the hospitalized older adult is made more complex by polypharmacy that can increase the risks of adverse drug events. This article reviews polypharmacy in the hospitalized older adult from their admission to hospitalization and transition of care as well as highlighting principles to reduce polypharmacy and tools for deprescribing during hospitalization. We review common reasons for admission and how these conditions may be particularly affected by or contribute to polypharmacy in older adults. Competing Interests: Disclosure The authors have nothing to disclose (Copyright © 2022 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |